Higher expression of whole blood microRNA-21 in patients with ankylosing spondylitis associated with programmed cell death 4 mRNA expression and collagen cross-linked C-telopeptide concentration

Chun Huang Huang, James Cheng Chung Wei, Wei Chiao Chang, Shang Yan Chiou, Chia Hsuan Chou, Yu Jie Lin, Pei Hsuan Hung, Ruey Hong Wong

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Objective. Bone loss is a recognized feature of ankylosing spondylitis (AS). The binding of microRNA-21 (miR-21) to programmed cell death 4 (PDCD4) could inhibit the expression of PDCD4 and further induce the activation of osteoclasts. In the present study, we compared the difference in miR-21 expression between patients with AS and healthy controls, and evaluated the relationships of miR-21, PDCD4 mRNA, and bone erosion in patients with AS. The influences of nonsteroidal antiinflammatory drugs (NSAID) and disease-modifying antirheumatic drugs (DMARD) on the expressions of miR-21 and PDCD4 mRNA in patients with AS were also assessed. Methods. Whole blood miR-21 and PDCD4 mRNA expression were evaluated by quantitative real-time PCR among 122 patients with AS and 122 healthy controls. The serum level of collagen cross-linked C-telopeptide (CTX) was measured using ELISA. Results. When compared to controls, patients with AS had significantly higher levels of miR-21, PDCD4 mRNA, and CTX. MiR-21 expression was negatively correlated with PDCD4 mRNA expression in patients with AS who were taking neither NSAID nor DMARD. Interestingly, significantly positive correlations between miR-21 expression with PDCD4 mRNA expression (r = 0.33, p = 0.01) and CTX level (r = 0.44, p <0.01) were observed in patients with AS who were taking sulfasalazine. Positive correlations of miR-21 and CTX level were also observed in AS patients with disease duration <7.0 years (r = 0.36, p = 0.004) and active disease (r = 0.42, p = 0.001). Conclusion. The expression of miR-21 might have a role in the development of AS. The Journal of Rheumatology

Original languageEnglish
Pages (from-to)1104-1111
Number of pages8
JournalJournal of Rheumatology
Volume41
Issue number6
DOIs
Publication statusPublished - 2014

Fingerprint

Ankylosing Spondylitis
MicroRNAs
Cell Death
Collagen
Messenger RNA
Antirheumatic Agents
Anti-Inflammatory Agents
collagen type I trimeric cross-linked peptide
Bone and Bones
Sulfasalazine
Rheumatology
Osteoclasts
Pharmaceutical Preparations
Real-Time Polymerase Chain Reaction
Enzyme-Linked Immunosorbent Assay

Keywords

  • Ankylosing spondylitis
  • Collagen cross-linked C-telopeptide
  • MicroRNA-21
  • Programmed cell death 4

ASJC Scopus subject areas

  • Rheumatology
  • Immunology
  • Immunology and Allergy
  • Medicine(all)

Cite this

Higher expression of whole blood microRNA-21 in patients with ankylosing spondylitis associated with programmed cell death 4 mRNA expression and collagen cross-linked C-telopeptide concentration. / Huang, Chun Huang; Wei, James Cheng Chung; Chang, Wei Chiao; Chiou, Shang Yan; Chou, Chia Hsuan; Lin, Yu Jie; Hung, Pei Hsuan; Wong, Ruey Hong.

In: Journal of Rheumatology, Vol. 41, No. 6, 2014, p. 1104-1111.

Research output: Contribution to journalArticle

Huang, Chun Huang ; Wei, James Cheng Chung ; Chang, Wei Chiao ; Chiou, Shang Yan ; Chou, Chia Hsuan ; Lin, Yu Jie ; Hung, Pei Hsuan ; Wong, Ruey Hong. / Higher expression of whole blood microRNA-21 in patients with ankylosing spondylitis associated with programmed cell death 4 mRNA expression and collagen cross-linked C-telopeptide concentration. In: Journal of Rheumatology. 2014 ; Vol. 41, No. 6. pp. 1104-1111.
@article{43b467a6f6d3441abe8331832c35fdd6,
title = "Higher expression of whole blood microRNA-21 in patients with ankylosing spondylitis associated with programmed cell death 4 mRNA expression and collagen cross-linked C-telopeptide concentration",
abstract = "Objective. Bone loss is a recognized feature of ankylosing spondylitis (AS). The binding of microRNA-21 (miR-21) to programmed cell death 4 (PDCD4) could inhibit the expression of PDCD4 and further induce the activation of osteoclasts. In the present study, we compared the difference in miR-21 expression between patients with AS and healthy controls, and evaluated the relationships of miR-21, PDCD4 mRNA, and bone erosion in patients with AS. The influences of nonsteroidal antiinflammatory drugs (NSAID) and disease-modifying antirheumatic drugs (DMARD) on the expressions of miR-21 and PDCD4 mRNA in patients with AS were also assessed. Methods. Whole blood miR-21 and PDCD4 mRNA expression were evaluated by quantitative real-time PCR among 122 patients with AS and 122 healthy controls. The serum level of collagen cross-linked C-telopeptide (CTX) was measured using ELISA. Results. When compared to controls, patients with AS had significantly higher levels of miR-21, PDCD4 mRNA, and CTX. MiR-21 expression was negatively correlated with PDCD4 mRNA expression in patients with AS who were taking neither NSAID nor DMARD. Interestingly, significantly positive correlations between miR-21 expression with PDCD4 mRNA expression (r = 0.33, p = 0.01) and CTX level (r = 0.44, p <0.01) were observed in patients with AS who were taking sulfasalazine. Positive correlations of miR-21 and CTX level were also observed in AS patients with disease duration <7.0 years (r = 0.36, p = 0.004) and active disease (r = 0.42, p = 0.001). Conclusion. The expression of miR-21 might have a role in the development of AS. The Journal of Rheumatology",
keywords = "Ankylosing spondylitis, Collagen cross-linked C-telopeptide, MicroRNA-21, Programmed cell death 4",
author = "Huang, {Chun Huang} and Wei, {James Cheng Chung} and Chang, {Wei Chiao} and Chiou, {Shang Yan} and Chou, {Chia Hsuan} and Lin, {Yu Jie} and Hung, {Pei Hsuan} and Wong, {Ruey Hong}",
year = "2014",
doi = "10.3899/jrheum.130515",
language = "English",
volume = "41",
pages = "1104--1111",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "6",

}

TY - JOUR

T1 - Higher expression of whole blood microRNA-21 in patients with ankylosing spondylitis associated with programmed cell death 4 mRNA expression and collagen cross-linked C-telopeptide concentration

AU - Huang, Chun Huang

AU - Wei, James Cheng Chung

AU - Chang, Wei Chiao

AU - Chiou, Shang Yan

AU - Chou, Chia Hsuan

AU - Lin, Yu Jie

AU - Hung, Pei Hsuan

AU - Wong, Ruey Hong

PY - 2014

Y1 - 2014

N2 - Objective. Bone loss is a recognized feature of ankylosing spondylitis (AS). The binding of microRNA-21 (miR-21) to programmed cell death 4 (PDCD4) could inhibit the expression of PDCD4 and further induce the activation of osteoclasts. In the present study, we compared the difference in miR-21 expression between patients with AS and healthy controls, and evaluated the relationships of miR-21, PDCD4 mRNA, and bone erosion in patients with AS. The influences of nonsteroidal antiinflammatory drugs (NSAID) and disease-modifying antirheumatic drugs (DMARD) on the expressions of miR-21 and PDCD4 mRNA in patients with AS were also assessed. Methods. Whole blood miR-21 and PDCD4 mRNA expression were evaluated by quantitative real-time PCR among 122 patients with AS and 122 healthy controls. The serum level of collagen cross-linked C-telopeptide (CTX) was measured using ELISA. Results. When compared to controls, patients with AS had significantly higher levels of miR-21, PDCD4 mRNA, and CTX. MiR-21 expression was negatively correlated with PDCD4 mRNA expression in patients with AS who were taking neither NSAID nor DMARD. Interestingly, significantly positive correlations between miR-21 expression with PDCD4 mRNA expression (r = 0.33, p = 0.01) and CTX level (r = 0.44, p <0.01) were observed in patients with AS who were taking sulfasalazine. Positive correlations of miR-21 and CTX level were also observed in AS patients with disease duration <7.0 years (r = 0.36, p = 0.004) and active disease (r = 0.42, p = 0.001). Conclusion. The expression of miR-21 might have a role in the development of AS. The Journal of Rheumatology

AB - Objective. Bone loss is a recognized feature of ankylosing spondylitis (AS). The binding of microRNA-21 (miR-21) to programmed cell death 4 (PDCD4) could inhibit the expression of PDCD4 and further induce the activation of osteoclasts. In the present study, we compared the difference in miR-21 expression between patients with AS and healthy controls, and evaluated the relationships of miR-21, PDCD4 mRNA, and bone erosion in patients with AS. The influences of nonsteroidal antiinflammatory drugs (NSAID) and disease-modifying antirheumatic drugs (DMARD) on the expressions of miR-21 and PDCD4 mRNA in patients with AS were also assessed. Methods. Whole blood miR-21 and PDCD4 mRNA expression were evaluated by quantitative real-time PCR among 122 patients with AS and 122 healthy controls. The serum level of collagen cross-linked C-telopeptide (CTX) was measured using ELISA. Results. When compared to controls, patients with AS had significantly higher levels of miR-21, PDCD4 mRNA, and CTX. MiR-21 expression was negatively correlated with PDCD4 mRNA expression in patients with AS who were taking neither NSAID nor DMARD. Interestingly, significantly positive correlations between miR-21 expression with PDCD4 mRNA expression (r = 0.33, p = 0.01) and CTX level (r = 0.44, p <0.01) were observed in patients with AS who were taking sulfasalazine. Positive correlations of miR-21 and CTX level were also observed in AS patients with disease duration <7.0 years (r = 0.36, p = 0.004) and active disease (r = 0.42, p = 0.001). Conclusion. The expression of miR-21 might have a role in the development of AS. The Journal of Rheumatology

KW - Ankylosing spondylitis

KW - Collagen cross-linked C-telopeptide

KW - MicroRNA-21

KW - Programmed cell death 4

UR - http://www.scopus.com/inward/record.url?scp=84901725791&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901725791&partnerID=8YFLogxK

U2 - 10.3899/jrheum.130515

DO - 10.3899/jrheum.130515

M3 - Article

C2 - 24786924

AN - SCOPUS:84901725791

VL - 41

SP - 1104

EP - 1111

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 6

ER -